Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Agenus

Request full access

Our goal is to treat cancers with novel combinations using our unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines & adjuvants

Lexington, United StatesFounded 1994Biotech & Life Sciences
Valuation $318M Market cap · Aug/2026
Revenue $185M Latest reported FY

At a glance

Status
Listed
Founded
1994
Headquarters
Lexington, United States
Listing
IPO 2000
Sector
Biotech & Life Sciences
Outcome tier
Thoroughbred$100M+ revenue

Knowledge graph

Founder mafias, market maps, lists and research connected to this company by Dealroom
Market maps in Biotech & Life Sciences
Market map Companies building biology-native data infrastructure Apr 30, 2026 Market map Rare Disease Therapeutics & Technologies Landscape Market map 1k+ Global Genetics & Genomics startups

Open roles

Track hiring at AgenusOpen roles, team growth and hiring by functionBook a demo
Looking for a job? The startup jobs board lists open roles.Startups hiring now →

Agenus in the Lexington ecosystem

Live from Dealroom

The Agenus office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • EW Healthcare Partners
  • Mentor Capital
  • Flagship Pioneering
  • Grazia Equity
  • BCM Ventures
  • Advent Life Sciences

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former Agenus employees who went on to found companies, sorted by Dealroom signal score.

EnvetecEst. 2021
Peter ThorntonIreland
Signal score74
MiNK TherapeuticsEst. 2017
Robert SteinUnited States
Signal score67
AbcuroEst. 2015
Stefano GullàUnited States
Signal score65
Tessera TherapeuticsEst. 2018
Noubar AfeyanUnited States
Signal score63
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
9 countries with
team presence
🇺🇸 United States84.7%
🇬🇧 United Kingdom11.1%
🇻🇳 Vietnam0.7%
🇨🇱 Chile0.7%
🇶🇦 Qatar0.7%
Top 5 of 9 shown
Web traffic by country
7.7K monthly visits
across markets
🇺🇸 United States45.5%
🇮🇳 India28.6%
🇯🇵 Japan11.7%
🇩🇪 Germany9.1%
🇫🇷 France6.5%
Top 5 markets shown

Patents

Estimated portfolio value
$117M

84 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Agenus on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Agenus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles